
Therapeutic Area | MeSH |
|---|---|
| nervous system diseases | D009422 |
| cardiovascular diseases | D002318 |
Brand Name | Status | Last Update |
|---|---|---|
| ticlopidine hydrochloride | ANDA | 2016-08-06 |
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| intracranial embolism and thrombosis | — | D002542 | — |
Code | Description |
|---|---|
| G9531 | Patient has documentation of ventricular shunt, brain tumor, multisystem trauma, or is currently taking an antiplatelet medication including: abciximab, anagrelide, cangrelor, cilostazol, clopidogrel, dipyridamole, eptifibatide, prasugrel, ticlopidine, ticagrelor, tirofiban, or vorapaxar |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 2 | — | — | — | — | 2 |
| Drug common name | Ticlopidine |
| INN | ticlopidine |
| Description | Ticlopidine is a thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group. It has a role as a fibrin modulating drug, a hematologic agent, an anticoagulant, a platelet aggregation inhibitor and a P2Y12 receptor antagonist. It is a thienopyridine and a member of monochlorobenzenes. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | Clc1ccccc1CN1CCc2sccc2C1 |
| PDB | — |
| CAS-ID | 55142-85-3 |
| RxCUI | — |
| ChEMBL ID | CHEMBL833 |
| ChEBI ID | 9588 |
| PubChem CID | 5472 |
| DrugBank | DB00208 |
| UNII ID | OM90ZUW7M1 (ChemIDplus, GSRS) |






